NR 565 Advanced Pharmacology - Week 1 Quiz Chamberlain University | 2026-2027
NR 565 Advanced Pharmacology
Week 1 Quiz - Actual Exam
Latest Update - Questions & Correct Verified Answers
100% Correct Verified Answers | Already A+ GRADE
Chamberlain University | College of Nursing & Public Health
Total Questions 50 Cognitive Level Distribution 25% Recall / 55% Application / 20% Analysis
Question Format Multiple Choice (A-D) Style Distribution 75% Scenario / 20% Direct Recall / 5% Case Analysis
Time Allocation 60 Minutes Passing Standard A+ Grade (100% Verified Correct)
Exam Overview: This comprehensive assessment evaluates advanced pharmacology foundational knowledge required for
the Nurse Practitioner role. The exam integrates pharmacokinetic and pharmacodynamic principles, drug development and
regulatory frameworks, drug interaction identification, and special population prescribing considerations. Each question
includes a verified correct answer and detailed rationale grounded in evidence-based practice, FDA regulations, DEA
prescribing standards, and current 2026-2027 clinical guidelines.
SECTION 1: Pharmacokinetics and Pharmacodynamics
Drug Absorption, Distribution, Metabolism, Excretion, Receptor Theory, & Dose-Response | Q1 - Q20
Q1: A patient receives 100 mg of a drug orally and achieves a peak plasma concentration of 20 mg/L. When
the same dose is administered intravenously, the peak plasma concentration is 40 mg/L. What is the oral
bioavailability of this drug?
A. 25%
B. 50% [CORRECT]
C. 75%
D. 100%
Correct Answer: B
Rationale: Bioavailability (F) is the fraction of administered drug that reaches systemic circulation unchanged,
calculated as (AUC_oral / AUC_IV) x 100. Using the concentration ratio: (20/40) x 100 = 50%. The IV route avoids
first-pass metabolism in the liver, so IV drugs are 100% bioavailable, while oral drugs undergo hepatic first-pass
metabolism, reducing bioavailability. This pharmacokinetic principle explains why oral doses often need to be higher
than IV doses to achieve equivalent therapeutic effect.
Verified Answers - 100% Correct | A+ Grade Page 1
,NR 565 Advanced Pharmacology - Week 1 Quiz Chamberlain University | 2026-2027
Q2: A 68-year-old patient with diabetic gastroparesis is prescribed an oral antibiotic for a urinary tract
infection. The NP knows that delayed gastric emptying will most directly affect which pharmacokinetic
process?
A. Distribution across the blood-brain barrier
B. Absorption from the GI tract [CORRECT]
C. Hepatic metabolism via CYP450
D. Renal tubular secretion
Correct Answer: B
Rationale: Gastric emptying directly influences the rate at which drugs reach the small intestine, where the majority of
GI drug absorption occurs due to the large surface area. Delayed gastric emptying (gastroparesis) slows the rate of
absorption, potentially delaying onset of action and reducing peak concentration. Distribution, metabolism, and
excretion occur after the drug enters systemic circulation and are not directly impacted by gastric motility.
Understanding absorption factors - surface area, blood flow, and gastric emptying - is essential for predicting drug
response in patients with altered GI function.
Q3: Volume of distribution (Vd) is best described as which of the following?
A. The actual volume of blood in which a drug is distributed
B. The total body water content of the patient
C. A hypothetical value reflecting the relationship between drug dosage and resulting blood levels
[CORRECT]
D. The volume of plasma cleared of drug per unit time
Correct Answer: C
Rationale: Volume of distribution is a hypothetical (theoretical) value that relates the administered dose to the resulting
plasma concentration, expressed as Vd = Dose / Plasma concentration. It does not represent a real anatomic
compartment; instead, it indicates how extensively a drug distributes into tissues. A large Vd suggests extensive tissue
distribution (e.g., lipophilic drugs), while a small Vd indicates confinement to plasma. Vd is essential for calculating
loading doses and understanding drug accumulation patterns. The volume of plasma cleared per unit time describes
clearance, not Vd.
Q4: Which statement best characterizes the cytochrome P450 (CYP450) enzyme system?
A. It performs Phase II conjugation reactions only
B. It is responsible for Phase 1 metabolism (oxidation, reduction, hydrolysis) of xenobiotics and contains
heme pigment [CORRECT]
C. It directly activates all prodrugs in the GI tract
D. It is located exclusively in the kidneys
Correct Answer: B
Rationale: The CYP450 enzyme system is a family of heme-containing enzymes bound to cell membranes (primarily
the smooth endoplasmic reticulum of hepatocytes) that catalyze Phase 1 metabolism reactions: oxidation, reduction, and
hydrolysis. These reactions introduce or expose functional groups on xenobiotics, preparing them for Phase II
conjugation. The heme pigment gives the enzymes their name (P450 refers to the absorption peak at 450 nm when
bound to carbon monoxide). CYP450 enzymes are most concentrated in the liver but also present in the gut, lungs, and
kidneys.
Verified Answers - 100% Correct | A+ Grade Page 2
, NR 565 Advanced Pharmacology - Week 1 Quiz Chamberlain University | 2026-2027
Q5: A patient stabilized on warfarin (metabolized by CYP2C9) begins taking ritonavir, a potent CYP2C9
inhibitor. The NP should anticipate which effect on warfarin levels and INR?
A. Decreased warfarin levels; decreased INR
B. Increased warfarin levels; increased INR with elevated bleeding risk [CORRECT]
C. No change in warfarin levels or INR
D. Decreased warfarin effect due to faster metabolism
Correct Answer: B
Rationale: CYP450 inhibitors decrease the metabolism of substrates, leading to increased drug levels and prolonged
half-life. Ritonavir inhibits CYP2C9, the primary enzyme metabolizing warfarin's more potent S-enantiomer. With
inhibited metabolism, warfarin accumulates, INR rises, and bleeding risk increases significantly. The NP should
monitor INR closely, anticipate dose reduction, and consider alternative therapy. In contrast, CYP450 inducers (e.g.,
rifampin, phenytoin, St. John's wort) would increase warfarin metabolism, lower drug levels, and decrease INR, raising
thrombosis risk.
Q6: A drug has a half-life of 12 hours. Assuming no loading dose is given and dosing occurs at the half-life
interval, approximately how long will it take to reach steady-state concentration?
A. 12 hours
B. 24 hours
C. 48 to 60 hours [CORRECT]
D. 7 days
Correct Answer: C
Rationale: Steady-state concentration is achieved after approximately 4 to 5 half-lives of repeated dosing. For a drug
with a 12-hour half-life: 4 x 12 = 48 hours; 5 x 12 = 60 hours. At steady state, the rate of drug administration equals the
rate of elimination, and plasma concentrations fluctuate between peak and trough but no longer accumulate. Half-life
also determines dosing intervals - drugs with short half-lives require more frequent dosing to maintain therapeutic
levels. A loading dose can achieve therapeutic levels rapidly when waiting 4-5 half-lives is clinically unacceptable.
Q7: Which of the following drugs has a narrow therapeutic index requiring routine serum concentration
monitoring?
A. Acetaminophen
B. Lisinopril
C. Digoxin [CORRECT]
D. Metformin
Correct Answer: C
Rationale: Digoxin has a narrow therapeutic index (typically 0.5 to 2.0 ng/mL), meaning the difference between
therapeutic and toxic doses is small. Other narrow therapeutic index drugs include lithium and warfarin. These
medications require serum concentration monitoring to ensure levels remain within the safe therapeutic window, as
minor dose changes or drug interactions can cause serious adverse effects. Acetaminophen, lisinopril, and metformin
have wider therapeutic margins and are typically monitored clinically rather than by serum levels.
Verified Answers - 100% Correct | A+ Grade Page 3
NR 565 Advanced Pharmacology
Week 1 Quiz - Actual Exam
Latest Update - Questions & Correct Verified Answers
100% Correct Verified Answers | Already A+ GRADE
Chamberlain University | College of Nursing & Public Health
Total Questions 50 Cognitive Level Distribution 25% Recall / 55% Application / 20% Analysis
Question Format Multiple Choice (A-D) Style Distribution 75% Scenario / 20% Direct Recall / 5% Case Analysis
Time Allocation 60 Minutes Passing Standard A+ Grade (100% Verified Correct)
Exam Overview: This comprehensive assessment evaluates advanced pharmacology foundational knowledge required for
the Nurse Practitioner role. The exam integrates pharmacokinetic and pharmacodynamic principles, drug development and
regulatory frameworks, drug interaction identification, and special population prescribing considerations. Each question
includes a verified correct answer and detailed rationale grounded in evidence-based practice, FDA regulations, DEA
prescribing standards, and current 2026-2027 clinical guidelines.
SECTION 1: Pharmacokinetics and Pharmacodynamics
Drug Absorption, Distribution, Metabolism, Excretion, Receptor Theory, & Dose-Response | Q1 - Q20
Q1: A patient receives 100 mg of a drug orally and achieves a peak plasma concentration of 20 mg/L. When
the same dose is administered intravenously, the peak plasma concentration is 40 mg/L. What is the oral
bioavailability of this drug?
A. 25%
B. 50% [CORRECT]
C. 75%
D. 100%
Correct Answer: B
Rationale: Bioavailability (F) is the fraction of administered drug that reaches systemic circulation unchanged,
calculated as (AUC_oral / AUC_IV) x 100. Using the concentration ratio: (20/40) x 100 = 50%. The IV route avoids
first-pass metabolism in the liver, so IV drugs are 100% bioavailable, while oral drugs undergo hepatic first-pass
metabolism, reducing bioavailability. This pharmacokinetic principle explains why oral doses often need to be higher
than IV doses to achieve equivalent therapeutic effect.
Verified Answers - 100% Correct | A+ Grade Page 1
,NR 565 Advanced Pharmacology - Week 1 Quiz Chamberlain University | 2026-2027
Q2: A 68-year-old patient with diabetic gastroparesis is prescribed an oral antibiotic for a urinary tract
infection. The NP knows that delayed gastric emptying will most directly affect which pharmacokinetic
process?
A. Distribution across the blood-brain barrier
B. Absorption from the GI tract [CORRECT]
C. Hepatic metabolism via CYP450
D. Renal tubular secretion
Correct Answer: B
Rationale: Gastric emptying directly influences the rate at which drugs reach the small intestine, where the majority of
GI drug absorption occurs due to the large surface area. Delayed gastric emptying (gastroparesis) slows the rate of
absorption, potentially delaying onset of action and reducing peak concentration. Distribution, metabolism, and
excretion occur after the drug enters systemic circulation and are not directly impacted by gastric motility.
Understanding absorption factors - surface area, blood flow, and gastric emptying - is essential for predicting drug
response in patients with altered GI function.
Q3: Volume of distribution (Vd) is best described as which of the following?
A. The actual volume of blood in which a drug is distributed
B. The total body water content of the patient
C. A hypothetical value reflecting the relationship between drug dosage and resulting blood levels
[CORRECT]
D. The volume of plasma cleared of drug per unit time
Correct Answer: C
Rationale: Volume of distribution is a hypothetical (theoretical) value that relates the administered dose to the resulting
plasma concentration, expressed as Vd = Dose / Plasma concentration. It does not represent a real anatomic
compartment; instead, it indicates how extensively a drug distributes into tissues. A large Vd suggests extensive tissue
distribution (e.g., lipophilic drugs), while a small Vd indicates confinement to plasma. Vd is essential for calculating
loading doses and understanding drug accumulation patterns. The volume of plasma cleared per unit time describes
clearance, not Vd.
Q4: Which statement best characterizes the cytochrome P450 (CYP450) enzyme system?
A. It performs Phase II conjugation reactions only
B. It is responsible for Phase 1 metabolism (oxidation, reduction, hydrolysis) of xenobiotics and contains
heme pigment [CORRECT]
C. It directly activates all prodrugs in the GI tract
D. It is located exclusively in the kidneys
Correct Answer: B
Rationale: The CYP450 enzyme system is a family of heme-containing enzymes bound to cell membranes (primarily
the smooth endoplasmic reticulum of hepatocytes) that catalyze Phase 1 metabolism reactions: oxidation, reduction, and
hydrolysis. These reactions introduce or expose functional groups on xenobiotics, preparing them for Phase II
conjugation. The heme pigment gives the enzymes their name (P450 refers to the absorption peak at 450 nm when
bound to carbon monoxide). CYP450 enzymes are most concentrated in the liver but also present in the gut, lungs, and
kidneys.
Verified Answers - 100% Correct | A+ Grade Page 2
, NR 565 Advanced Pharmacology - Week 1 Quiz Chamberlain University | 2026-2027
Q5: A patient stabilized on warfarin (metabolized by CYP2C9) begins taking ritonavir, a potent CYP2C9
inhibitor. The NP should anticipate which effect on warfarin levels and INR?
A. Decreased warfarin levels; decreased INR
B. Increased warfarin levels; increased INR with elevated bleeding risk [CORRECT]
C. No change in warfarin levels or INR
D. Decreased warfarin effect due to faster metabolism
Correct Answer: B
Rationale: CYP450 inhibitors decrease the metabolism of substrates, leading to increased drug levels and prolonged
half-life. Ritonavir inhibits CYP2C9, the primary enzyme metabolizing warfarin's more potent S-enantiomer. With
inhibited metabolism, warfarin accumulates, INR rises, and bleeding risk increases significantly. The NP should
monitor INR closely, anticipate dose reduction, and consider alternative therapy. In contrast, CYP450 inducers (e.g.,
rifampin, phenytoin, St. John's wort) would increase warfarin metabolism, lower drug levels, and decrease INR, raising
thrombosis risk.
Q6: A drug has a half-life of 12 hours. Assuming no loading dose is given and dosing occurs at the half-life
interval, approximately how long will it take to reach steady-state concentration?
A. 12 hours
B. 24 hours
C. 48 to 60 hours [CORRECT]
D. 7 days
Correct Answer: C
Rationale: Steady-state concentration is achieved after approximately 4 to 5 half-lives of repeated dosing. For a drug
with a 12-hour half-life: 4 x 12 = 48 hours; 5 x 12 = 60 hours. At steady state, the rate of drug administration equals the
rate of elimination, and plasma concentrations fluctuate between peak and trough but no longer accumulate. Half-life
also determines dosing intervals - drugs with short half-lives require more frequent dosing to maintain therapeutic
levels. A loading dose can achieve therapeutic levels rapidly when waiting 4-5 half-lives is clinically unacceptable.
Q7: Which of the following drugs has a narrow therapeutic index requiring routine serum concentration
monitoring?
A. Acetaminophen
B. Lisinopril
C. Digoxin [CORRECT]
D. Metformin
Correct Answer: C
Rationale: Digoxin has a narrow therapeutic index (typically 0.5 to 2.0 ng/mL), meaning the difference between
therapeutic and toxic doses is small. Other narrow therapeutic index drugs include lithium and warfarin. These
medications require serum concentration monitoring to ensure levels remain within the safe therapeutic window, as
minor dose changes or drug interactions can cause serious adverse effects. Acetaminophen, lisinopril, and metformin
have wider therapeutic margins and are typically monitored clinically rather than by serum levels.
Verified Answers - 100% Correct | A+ Grade Page 3
